Dr. David Becker-Weidman is an Assistant Member in the Department of Diagnostic Imaging and Interventional Radiology. Dr. Becker-Weidman earned his MD at Emory University School of Medicine. He completed a Diagnostic Radiology residency at Thomas Jefferson University, followed by a Body MRI fellowship at Beth Israel Deaconess Medical Center. Dr. Becker-Weidman was most recently on staff as an attending physician at Buffalo VA Medical Center in New York. Dr. Becker-Weidman is interested in all aspects of body imaging, specifically in MRI of the abdomen and pelvis, as well as image-guided intervention.
Education & Training
Beth Israel Deaconess Medical Center - Body MRI
Thomas Jefferson University - Diagnostic Radiology
Becker-Weidman D, Chung CMC, Nadeem M, Virk J, Chung C. Computed Tomography Findings in Vernix Caseosa Peritonitis. J Comput Assist Tomo. 2020 Sep.44(5):780-783. Pubmedid: 32842059.
Virk J, Smock B, Nadeem M, Chung C, Maynor C, Becker-Weidman D, Mangano T. The Use of Periareolar Topical Lidocaine Jelly After Needle Localization May Reduce Pain of Subsequent Lymphoscintigraphy. Cureus. 2020 Apr.12(4):e7861. Pubmedid: 32483511. Pmcid: PMC7255066.
Becker-Weidman D, Mhuircheartaigh JN, Mortele KJ. The skinny on skin: MRI features of cutaneous and subcutaneous lesions detected on body MRI studies. Abdom Radiol (NY). 2018 Oct.43(10):2823-2850. Pubmedid: 29525881.
Becker-Weidman D, Floré B, Mortelé KJ. Xanthogranulomatous pancreatitis: A review of the imaging characteristics of this rare and often misdiagnosed lesion of the pancreas. Clin Imaging. 2017 Sep.45:12-17. Pubmedid: 28554050.
Becker-Weidman DJ, Malhotra N, Reilly DF, Selvam N, Parker L, Nazarian LN. Imaging Surveillance in Patients After a Benign Fine-Needle Aspiration Biopsy of the Thyroid: Associated Cost and Incidence of Subsequent Cancer. Ajr Am J Roentgenol. 2017 Feb.208(2):358-361. Pubmedid: 27929675.
Perillo M, Becker-Weidman D, Bezuidenhout AF, Siewert B, Eisenberg RL. Infections of the Gastrointestinal Tract. Semin Roentgenol. 2017 Apr.52(2):63-72. Pubmedid: 28606310.
Becker-Weidman D, Civan JM, Deshmukh SP, Roth CG, Herrine SK, Parker L, Mitchell DG. Hepatocellular carcinoma after locoregional therapy: Magnetic resonance imaging findings in falsely negative exams. World J Hepatol. 2016 Jun.8(16):685-690. Pubmedid: 27326315. Pmcid: PMC4909430.
Becker-Weidman DJ, Hope TA, Doshi PH, Patel A, Mitchell DG. Transient washout of hepatic hemangiomas: Potential pitfall mimicking malignancy. Radiol Case Rep. 2016 Apr.11(2):62-66. Pubmedid: 27257451. Pmcid: PMC4878935.
Becker-Weidman D, Kalb B, Mittal PK, Harri PA, Arif-Tiwari H, Farris AB, Chen Z, Sungjin K, Martin DR. Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: Utility of dynamic, contrast enhancement and single-shot T2-weighted sequences. Eur J Radiol. 2015 Nov.84(11):2045-2051. Pubmedid: 26233268.
Becker-Weidman DJ, Kalb B, Sharma P, Kitajima HD, Lurie CR, Chen Z, Spivey JR, Knechtle SJ, Hanish SI, Adsay NV, Farris AB, Martin DR. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements. Radiology. 2011 Dec.261(3):824-833. Pubmedid: 21969663.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub